Health Assessment Questionnaire

Related by string. * health . HealthEd . HEALTH : HEALTH CARE FACILITIES INDUSTRY . HEALTH CARE REFORM . Health Protection Agency / assessments . assessment . Assessments : Florida Comprehensive Assessment . Special Protocol Assessment . Massachusetts Comprehensive Assessment / Questionnaires . questionnaires . questionnaire : census questionnaire . Difficulties Questionnaire * *

Related by context. All words. (Click for frequent words.) 77 Index HAQ DI 72 WOMAC pain 71 Disease Activity 71 HAQ DI 71 Visual Analog Scale 71 Expanded Disability Status 70 Montgomery Asberg Depression 70 Rating Scale MADRS 70 Scale EDSS 70 WOMAC 70 subscales 69 Score DAS 69 subscale scores 69 HRQL 69 Brief Psychiatric 69 Alzheimer Disease Assessment 69 NIH CPSI 68 Montgomery Åsberg Depression 68 QoL 68 Global Impression CGI 68 IBDQ 68 Functional Assessment 68 Status Scale EDSS 68 EQ 5D 68 Oswestry Disability Index 68 DAS# CRP 67 Crohn Disease Activity 67 HRQOL 66 DAS# [002] 66 Index CDAI 66 Functional Outcomes 66 PANSS 66 HRQoL 66 HADS 66 symptom severity 66 Rating Scale 66 Fibromyalgia Impact Questionnaire 66 HDRS 66 Visual Analogue Scale VAS 65 WOMAC TM 65 SGRQ 65 Psoriasis Area 65 Physical Component 65 Unified Parkinson Disease 65 Symptom severity 65 Global Impression 65 NIHSS 65 Negative Syndrome 65 BMI z 65 UPDRS 64 Physical Function 64 ADCS CGIC 64 Brief Pain 64 Rating Scale UPDRS 64 subscores 64 Pain Rating Scale 64 clinically meaningful improvement 64 State Examination MMSE 64 SF #v# 64 Assessment Scale 64 ADAS cog 64 Scale PANSS 64 International Prostate Symptom 64 Primary endpoints 64 Symptom Checklist 64 Comorbidity 64 SELENA SLEDAI 64 Neuropsychiatric Inventory 64 mTSS 64 Inventory BPI 64 McGill Pain Questionnaire 64 MADRS 64 subscore 64 Score TOS 64 Outcomes Study 63 pain subscale 63 albumin excretion rate 63 Dyspnea 63 Symptom Severity 63 cognitive affective 63 Skin sterol 63 left ventricular diastolic 63 EDSS score 63 Main Outcome Measures 63 Severity Index PASI 63 Geriatric Depression 63 Index WOMAC 63 PSQI 63 HAM D# 63 mRS 63 Rating Scale BPRS 63 HAQ 63 PANSS total 63 IRLS 62 ADAS Cog 62 NIS LL 62 bronchial hyperresponsiveness 62 APACHE II 62 CDAI 62 Visual Analog 62 Scale cognitive subscale 62 Neuropsychiatric Inventory NPI 62 ASIA Impairment 62 HOMA IR 62 erythrocyte sedimentation rate 62 Negative Symptoms 62 Abnormal Involuntary Movement 62 DAS# scores 62 Lower Limb 62 CORE OM 62 YMRS 62 Y BOCS 62 MMSE score 62 Depressive Symptoms 62 Ocular Surface Disease 62 apnea hypopnea index 61 Distress Scale 61 liver histology 61 Cognitive Function 61 Visual Analogue Scale 61 Ejection Fraction 61 Chronic Illness Therapy 61 depressive symptomatology 61 Severity Index 61 Score IPSS 61 CNS LS 61 intraobserver 61 enthesitis 61 Clinician Administered PTSD 61 acetabular dysplasia 61 QIDS SR 61 odds ratios ORs 61 EDSS 61 Scale Cognitive Subscale 61 Score DAS# 61 preoperatively 61 non menstrual pelvic 61 Glasgow Coma Scale 61 Main Outcome Measure 61 estimated glomerular filtration 61 euthymic patients 61 Mental Component 61 WOMAC scores 60 Meta Analysis 60 aMCI precursor 60 PCWP 60 Treatment Outcome 60 Stroke Scale 60 biopsy Gleason 60 8mg/kg 60 ADHD Rating Scale 60 Hamilton Anxiety Scale 60 NIHSS score 60 HAMD 60 poststroke 60 lowest tertile 60 interrater reliability 60 SGOT 60 radiographic progression 60 intact parathyroid hormone 60 Severity MSCS score 60 abdominal pain abdominal discomfort 60 Insulin sensitivity 60 endometrial thickness 60 Histologic 60 PsA 60 MADRS score 60 Scale EDSS score 60 UPDRS motor 60 Incontinence Impact Questionnaire 60 morphometric vertebral fractures 60 tissue oxygenation 60 Rheumatoid 60 hip BMD 60 neurocognitive function 60 Mini Mental 60 Preoperatively 60 anthropometric measures 60 clinically meaningful improvements 60 interobserver 60 Depression Rating Scale 59 plus methotrexate 59 Hypertrophy 59 RECIST Response Evaluation Criteria 59 VFQ 59 Global Impression Severity 59 T2DM 59 artery stenosis 59 ADCS ADL 59 Acute Physiology 59 -#.# ± [002] 59 function subscale 59 vasomotor 59 Stroke Scale NIHSS 59 Ishak fibrosis score 59 Generalized Anxiety Disorder 59 Natalizumab 59 Secondary endpoints included 59 Oral Fingolimod 59 NYHA functional class 59 multivariable analysis 59 EORTC QLQ C# 59 lactate dehydrogenase 59 Left Ventricular 59 triiodothyronine 59 psychometric properties 59 aspartate aminotransferase AST 59 CIMZIA TM certolizumab pegol 59 NNT = 59 left ventricular LV 59 autonomic dysfunction 59 lumbar spine BMD 59 Cardiorespiratory fitness 59 alanine aminotransferase ALT 59 mineral density BMD 59 transcranial Doppler ultrasound 59 Fracture Risk 59 subsyndromal 59 Comorbidities 59 Respiratory Symptoms 59 Symptom Scale 59 glomerular filtration 59 MMSE scores 59 Injury Severity Score 59 Wechsler Adult 59 rhinoconjunctivitis 59 flow mediated dilation 59 annualized relapse 59 electrophysiologic 59 Outcome Measures 59 serum IGF 59 IIEF 59 psychosocial functioning 59 neurologic impairment 59 Hamilton Rating Scale 59 Cronbach alpha 59 fasting insulin 59 Clinical Outcome 59 Neurocognitive 59 haematologic 59 Myocardial Infarction TIMI 59 aspartate aminotransferase 59 F FDG PET 59 corticosteroid dose 58 hematological parameters 58 leukocyte counts 58 psychosocial variables 58 Depression Inventory 58 moderate renal impairment 58 DLQI 58 semiquantitative 58 Seattle Angina Questionnaire 58 CIBIC plus 58 Prognostic 58 HAM D 58 HLA DR4 58 multivariable adjusted 58 BPS IC 58 Relapsing Multiple Sclerosis 58 Left Ventricular Ejection Fraction 58 Orthostatic Hypotension 58 cortical atrophy 58 premorbid 58 Solid Tumors criteria 58 Postoperatively 58 exploratory endpoints 58 somatic symptoms 58 fasting plasma 58 nerve conduction velocity 58 atrophic gastritis 58 logistic regression analyzes 58 Risk Stratification 58 nasal symptom 58 secondary efficacy endpoint 58 Erectile Function 58 Solid Tumors 58 QRS duration 58 akinesia 58 Progenitor Cells 58 SGPT 58 convergent validity 58 erection hardness 58 BILAG 58 polyarticular 58 subtests 58 dyspnoea 58 IPSS 58 Doppler echocardiography 58 Intervention Trial 58 Secondary endpoints 58 Cognitive Impairment 58 IRLS score 58 psychopathological symptoms 58 CI #.#-#.# [001] 58 Secondary endpoints include 58 MMSE 58 postoperative AF 58 Endocrine Therapy 58 Myocardial infarction 58 Predict Risk 58 BPH symptom 58 multivariate Cox 58 overnight polysomnography 58 urine albumin 58 LV ejection fraction 58 oral antidiabetic medication 58 Thrombolysis 58 experimentally induced 58 vascular reactivity 58 KOOS 58 femoral neck BMD 58 prospectively evaluated 58 CCyR 58 #q# deletion syndrome 58 STRATEGY FOR AN OPEN 58 NPRS 58 diabetes mellitus DM 58 adenotonsillectomy 58 retest reliability 58 colorectal adenoma 58 Persistent Sleep 58 CDAI score 58 UPDRS Part III 58 knee osteoarthritis OA 58 Nonspecific 58 Pain Intensity 58 Diabetic Foot Ulcer 58 exhaled nitric oxide 58 Epworth Sleepiness Scale 57 Spasticity 57 Subarachnoid hemorrhage 57 logistic regression model 57 amnestic mild cognitive impairment 57 interobserver reliability 57 Juvenile Idiopathic Arthritis 57 Serum concentrations 57 plasma lipids 57 euthymic 57 Patients Receiving 57 Response Evaluation Criteria 57 myocardial viability 57 waist circumference WC 57 methacholine challenge 57 Annualized Relapse Rate ARR 57 vitreous floaters 57 Heritability 57 artery elasticity 57 Sociodemographic 57 cardiac autonomic 57 CC genotype 57 PANSS scores 57 affective psychoses 57 ACR Pedi 57 hemodynamic measurements 57 mL/min/#.# m 2 57 Logistic regression 57 Hemoglobin A1c 57 Anxiety Depression 57 p = .# [002] 57 Child Behavior Checklist 57 INVEGA ® 57 Ischemic Stroke 57 Bosentan 57 CI -#.# 57 Cerebellar 57 PLMS 57 glycosylated hemoglobin HbA1c 57 Chronic HCV 57 carotid artery intima media 57 tibiofemoral 57 hyperreflexia 57 McMaster Universities Osteoarthritis 57 CrCl 57 Cystic Fibrosis Questionnaire Revised 57 Erectile Function IIEF 57 Beck Anxiety Inventory 57 Mean Symptom Complex 57 hemoglobin A1c HbA1c 57 WAIS III 57 hyperphenylalaninemia HPA due 57 reactive hyperemia 57 Visual acuity 57 ALS Functional 57 lopinavir r arm 57 -#.# log# copies mL 57 Intraocular Pressure 57 IKDC 57 lumbar spine bone 57 DAS# remission 57 intraclass correlation coefficient 57 nonobese 57 Renal Function 57 Levels Linked 57 spirometric 57 mediated dilation 57 QOL 57 6MWD 57 oxygen desaturation 57 peak VO2 57 Knee Osteoarthritis 57 baseline PASI 57 serum cortisol 57 Pearson correlation coefficient 57 Knee osteoarthritis 57 aminotransferase levels 57 clinically meaningful reductions 57 hepatic enzyme 57 hemoglobin A1c levels 57 budesonide pMDI 57 EDSS scores 57 gastroduodenal 57 intra articular injection 57 Timed Walk 57 % Confidence Interval 57 postinjury 57 alanine aminotransferase 57 intima media thickness 57 hyperalgesia 57 dimensional echocardiography 57 Ashworth Scale 57 MetS 57 Ischemic 57 Secondary efficacy endpoints 57 urinary N telopeptide 57 confidence intervals CIs 57 Patency 57 fractional anisotropy 57 mucosal healing 57 capillary density 57 Subclinical 57 mcg QD 57 ± SD 57 prospectively defined 57 Severity Scale 57 function subscales 57 methotrexate monotherapy 57 Cardiac Resynchronization 57 creatinine ratio 57 Female Sexual Function 57 Symptom Score 57 inhibin 57 4mg/kg 57 prospectively stratified 57 psoriatic arthritis PsA 57 postoperative complication 57 FACIT Fatigue 57 PSADT 56 urinary albumin 56 daytime somnolence 56 Randomized Controlled Trials 56 Psychological Distress 56 Prospective Randomized 56 ALT AST 56 hemoglobin Hb 56 Kidney Function 56 Univariate 56 baseline serum creatinine 56 Coronary Artery Calcium 56 aminotransferase 56 adjunctive placebo 56 Wechsler Intelligence 56 nonarteritic anterior ischemic optic 56 Fasting plasma glucose 56 Cystatin C 56 nondiabetic patients 56 SRBD 56 Postoperative 56 coronary stenosis 56 Depressive symptoms 56 OSDI 56 Assessment Questionnaire 56 Pearson correlation coefficients 56 State Exam MMSE 56 % CI #.#-#.# [005] 56 Tumor Response 56 echocardiographic parameters 56 lymphocyte count 56 Claudication 56 Controlled Trial 56 Comorbid 56 Index CDAI score 56 Hemodialysis Patients 56 LDL HDL 56 PASI scores 56 highest tertile 56 thyrotropin levels 56 comorbid anxiety 56 daytime alertness 56 systolic function 56 Symptom 56 IELT 56 mild renal insufficiency 56 oxycodone CR 56 ‰ ¥ 56 aminotransferases 56 intraclass correlation coefficients 56 Glomerular Filtration Rate 56 demonstrated clinically meaningful 56 preoperative PSA 56 carotid IMT 56 Efficacy endpoints 56 parkinsonian 56 Depression Scale 56 Evaluable 56 fructosamine 56 histologically proven 56 SLEDAI 56 Multivariate analysis 56 extracorporeal shock wave 56 Cholinesterase Inhibitors 56 hippocampal volumes 56 pharmacodynamic parameters 56 Severe Asthma 56 creatinine clearance 56 albumin excretion 56 pelvic lymphadenectomy 56 progression TTP 56 bone erosions 56 Kaplan Meier analysis 56 cerebral oxygenation 56 psychiatric comorbidity 56 posttest 56 plain radiographs 56 Rating Scale IRLS 56 vitreous haze 56 leukocyte count 56 biochemical relapse 56 CD4 CD8 56 cerebral perfusion 56 QTcF 56 juvenile idiopathic arthritis 56 glutamic acid decarboxylase 56 somatostatin analog 56 extrapyramidal symptoms 56 isoprostane 56 affective psychosis 56 glycated hemoglobin levels 56 nausea photophobia 56 abdominal circumference 56 postmenopausal osteoporotic women 56 salivary cortisol 56 bioavailable testosterone 56 Bone Mineral Density 56 handgrip strength 56 deep venous thromboses 56 moderate hepatic impairment 56 hepatic fibrosis 56 Renal dysfunction 56 multivariable Cox 56 rFSH 56 aromatase inhibitor therapy 56 RAPAFLO R 56 elevated transaminases 56 AST ALT 56 serum phosphate 56 actigraphy 56 nonvertebral fracture 56 SSRI citalopram 56 Edinburgh Postnatal Depression 56 Non Alcoholic Steatohepatitis 56 elevated IOP 56 Endothelial function 56 ejection fractions 56 metabolic syndrome MetS 56 ANOVA 56 virological response 56 Subscale 56 meta regression 56 GH deficiency 56 visceral adiposity 56 NMES 56 Cognitive Abilities Test 56 glomerular filtration rate 56 Numeric Rating Scale 56 pyridostigmine 56 Preoperative 56 Heart Failure Patients 56 nonfasting triglyceride levels 56 Relapsing Remitting Multiple Sclerosis 56 response CCyR 56 serum aminotransferase levels 56 Placebo Controlled Trial 56 metabolic parameters 56 impaired glucose metabolism 56 EBMT criteria 56 covariate 56 tissue perfusion 56 gadolinium enhancing lesions 56 adjunctive ABILIFY 56 logistic regression analysis 56 mean ± SEM 56 multivariate regression analysis 56 posttransplant 56 overactive bladder symptoms 56 Wechsler Memory 56 fasting plasma glucose FPG 56 HER2 expression 56 multivariate analyzes 56 Subgroup analysis 56 tipranavir r 56 % CI #.#-#.# [007] 56 dehydroepiandrosterone sulfate 56 Ankylosing Spondylitis 56 QD dosing 56 Retreatment 56 preintervention 56 CHADS2 56 physiologic parameters 56 maximal treadmill 56 serologically active patients 56 desvenlafaxine succinate 56 depressive symptom 55 Clinical Relevance 55 fatty infiltration 55 subclinical atherosclerosis 55 Non inferiority 55 ST Segment Elevation 55 55 Inflammatory Pain 55 Anxiety Scale 55 Hb A1C 55 autoimmune thyroid 55 International Prognostic Scoring 55 Antiviral Therapy 55 Systematic Review 55 cardio respiratory fitness 55 troponin T 55 Remission Maintenance 55 Catheter Associated 55 HbA 1c 55 confirmed CCyR 55 shorter telomere length 55 Hyperlipidemia 55 Diabetic Neuropathy 55 Histological 55 allostatic load 55 transaminase 55 lactate dehydrogenase LDH 55 Atopic Dermatitis 55 comorbid depression 55 CLBP 55 % CI #.#-#.# [003] 55 CSBMs 55 PSA nadir 55 Improves Outcomes 55 subtest 55 EDEMA3 trial 55 serum PTH 55 STRIDE PD 55 multivariate logistic regression 55 ecchymosis 55 ETDRS 55 histological subtype 55 nontraumatic 55 Chronic Insomnia 55 Subgroup Analysis 55 CD# expression [002] 55 Gene Mutation Linked 55 plasma homocysteine 55 Bipolar Disorder STEP BD 55 left ventricular systolic 55 generalized anxiety disorder GAD 55 Univariate analysis 55 glucocorticoid therapy 55 Lower Extremity 55 symptomatic VTE 55 perioperative complications 55 Ankle Brachial Index 55 Chronic Heart Failure 55 Interrater reliability 55 Kaplan Meier method 55 CIBIC + 55 lumbar disk herniation 55 underwent resection 55 mRNA expression 55 femoral neck bone 55 atherogenic dyslipidemia 55 sensory neuropathy 55 ACTEMRA TM 55 platelet reactivity 55 ANCOVA 55 Lesion 55 clinical meaningfulness 55 RLS symptoms 55 metabolite concentrations 55 mean baseline A1C 55 TIMP 1 55 PANSS Positive 55 = #.#-#.# 55 activated partial thromboplastin 55 CONCERTA ® 55 unpaired t 55 Coronary artery calcium 55 ß = 55 CRp 55 Charlson Comorbidity Index 55 Cognitive Problems 55 nasal obstruction 55 Kruskal Wallis test 55 C Reactive Protein 55 Short Stature 55 Systemic Sclerosis 55 inflammatory biomarkers 55 Atherosclerotic 55 Hb A1c 55 dose Iluvien 55 intermittent claudication 55 alexithymia 55 elevated ALT 55 macroalbuminuria 55 baseline FEV 55 serum sodium levels 55 steroid dexamethasone 55 Tasigna prolongs 55 elevated creatinine 55 euthyroid 55 Bioavailability 55 Peripheral Arterial 55 SCr 55 tryptophan depletion 55 CSBM 55 secondary endpoint 55 proton MR spectroscopy 55 ratio WHR 55 Non Responders 55 OSAHS 55 placebo p = 55 serum testosterone 55 asthma exacerbation 55 antibody titer 55 Vertebral Fractures 55 hallux valgus 55 Glomerular filtration rate 55 Metastatic Prostate Cancer 55 oral glucose tolerance 55 plasma cortisol 55 Depressive Symptomatology 55 emotional lability 55 Patients Treated With 55 hematologic parameters 55 hypercalciuria 55 Desvenlafaxine Succinate 55 Subtypes 55 RENAL 55 arterial calcification 55 Adalimumab 55 baroreceptor 55 LVEF 55 mitral annular 55 aPTT 55 Diagnostic Criteria 55 State Trait Anxiety 55 symptom checklist 55 bronchopulmonary dysplasia BPD 55 Hypercholesterolemia 55 anemia hemoglobin 55 neurocognitive deficits 55 hepatic enzymes 55 MoxDuo TM IR 55 Bone Metastases 55 REYATAZ r arm 55 GERD symptom 55 PREZISTA r arm 55 % CI #.#-#.# [006] 55 dapagliflozin plus 55 univariate analyzes 55 histologic findings 55 neurodevelopmental outcome 55 x ULN 55 Gene Linked 55 bronchoalveolar lavage fluid 55 adrenal function 55 PERMP 55 hepatic cirrhosis 55 PEG IFN 55 FDG-PET/CT 55 carotid intima media 55 brachial artery flow 55 APOE genotype 55 Lumbar spine 55 intima media thickness IMT 55 fatigability 55 Cognitive Deficits 55 Tiotropium 55 airway hyperresponsiveness 55 mg TID 55 ropivacaine 55 serum phosphorous 55 hemiparesis 55 plasma glucose concentration 55 6MWT 55 surgically resected 55 diabetic polyneuropathy 55 System IPSS 55 longitudinal observational study 55 repetitive transcranial magnetic stimulation 55 cerebral atrophy 55 Elderly Patients 55 serum estradiol 55 foveal thickness 55 transaminase levels 55 relapsing multiple sclerosis 55 Inhaled Corticosteroids 55 Mania Rating Scale 55 IOP lowering 55 nonoperative treatment 55 diabetes dyslipidemia 55 J Am Soc 55 constipation predominant IBS 55 Functioning GAF 54 Ventricular Arrhythmias 54 Prognostic significance 54 Mouse Model 54 serum prostate 54 Electrical Stimulation 54 serum parathyroid hormone 54 Pelvic Organ Prolapse 54 correlation coefficients 54 neuromuscular electrical stimulation 54 ankle brachial index 54 chills fever headache 54 Platelet counts 54 calculated creatinine clearance 54 d dimer 54 locomotor activity 54 PLX STROKE targeting 54 tertile 54 Arterial Disease 54 postprocedure 54 Hypertensive Patients 54 gait disturbances 54 BMI waist circumference 54 DEXA scan 54 Change PGIC 54 Pioglitazone 54 thyroglobulin 54 Myocardial 54 univariate analysis 54 osteopenic 54 NSAID associated 54 Ischaemic 54 microalbuminuria 54 osteoarthritic 54 multi infarct dementia 54 myocardial reperfusion 54 P = .# 54 Pediatric Patients 54 Demonstrates Significant 54 rCBF 54 Lymphocyte 54 Proteinuria 54 multiple linear regression 54 histologic 54 Alzheimer Disease Cooperative 54 Albuminuria 54 sulfasalazine 54 iPTH 54 mIU L 54 pathologic fracture 54 tapentadol ER 54 extraocular 54 Randomized Controlled Trial 54 urinary albumin excretion 54 Posttraumatic 54 CTEPH 54 Cockcroft Gault 54 quantitative computed tomography 54 bortezomib refractory 54 thyrotropin 54 Impressions Improvement 54 electroencephalographic 54 Functional Capacity 54 Nesiritide 54 Virologic 54 synovitis 54 hyper IgE syndrome 54 subjective sleepiness 54 axonal damage 54 decrements 54 imipramine Tofranil 54 allele frequencies 54 baseline A1C 54 MSLT 54 vasopressor 54 Sleep Disturbances 54 intravascular hemolysis 54 inhaled budesonide 54 bronchoalveolar lavage BAL 54 transaminases 54 serum lipid levels 54 tumor histology 54 Ann Emerg Med 54 glucocorticoid induced 54 generalized edema 54 Lymphocytic 54 virologic responses 54 Hepatic Encephalopathy 54 sUA 54 dactylitis 54 CLINICAL PHARMACOLOGY 54 hours postdose 54 PLMs 54 BPRS 54 Predictors 54 baseline HbA1c 54 logistic regression 54 infraspinatus 54 Study Evaluating 54 Atypical Hemolytic Uremic Syndrome 54 Endothelial Function 54 ADHD RS 54 Echocardiographic 54 achieved ACR# 54 neuropsychological assessments 54 Castration Resistant Prostate Cancer 54 binary logistic regression 54 neuritic 54 FDG PET scans 54 ABCB1 54 Demonstrates Efficacy 54 multiple logistic regression 54 mcg BID 54 Primary Endpoint 54 eNO 54 preoperative diagnosis 54 Treated Patients 54 -#.# mg dL [002] 54 Histopathologic 54 adenoma recurrence 54 aminotransferase ALT 54 retinal thickness 54 leucopenia 54 neurocognitive impairment 54 submaximal 54 point Likert scale 54 SSRI SNRI 54 Secondary Hyperparathyroidism 54 variceal bleeding 54 Treating Chronic 54 clinico pathological 54 Beta Blockers 54 spontaneous bowel movements 54 postoperative mortality 54 mineral density 54 creatine kinase 54 Cognitive Decline 54 abdominal adiposity 54 macular edema secondary 54 Myocardial Infarction Study 54 Shows Statistically Significant 54 neurocognitive functioning 54 pT3 54 Arch Intern Med 54 ACE Inhibitors 54 bivariate analyzes 54 neuromotor 54 pT2 54 hippocampal atrophy 54 Nonalcoholic Fatty Liver Disease 54 HMG CoA reductase inhibitor 54 ADPKD 54 posttreatment 54 nonvertebral fractures 54 T1 weighted images 54 FDG PET imaging 54 prognostic variables 54 Tardive dyskinesia 54 Arm Shoulder 54 dysuria 54 Demonstrated Significant 54 afterload 54 tibiofibular 54 #.#ng/ml 54 aneurysmal subarachnoid hemorrhage 54 adrenocortical 54 hypophosphatemia 54 PHQ 9 54 infliximab monotherapy 54 Long Term Efficacy 54 Decitabine 54 salmeterol fluticasone 54 neurologic progression 54 Contrast Agent 54 univariate 54 polysomnography PSG 54 pulmonary arterial 54 CR nPR 54 contrast echocardiography 54 TNSS 54 Cerebrospinal Fluid 54 estimated GFR 54 Psychotic Disorders 54 -#.# mg dL [001] 54 transient elastography 54 Systolic Blood Pressure 54 p tau 54 COPD exacerbation 54 logMAR 54 lipid profiles

Back to home page